| Log in

PE-backed Thyrocare founder on adopting a B2C model, exploring talks with strategic investor

12 May, 2014

In an exclusive video interview with VCCircle, Dr A Velumani, founder and chairman of Thyrocare Technologies Ltd, explains the rationale behind going B2C and acquisition plans as well as talks on exploring a strategic sale. Thyrocare, India’s largest thyroid testing company, is floating a chain of laboratories called Lab Nation, which will follow a business to consumer (B2C) model. CX Partners invested in the company in 2010, picking up the stake from promoters with some primary infusion. Early last year, Nueclear Healthcare Ltd, the low-cost cancer diagnosis services business of the Thyrocare group, raised Rs 22 crore ($4 million) from Norwest Venture Partners. The firm is planning to set up 120 molecular imaging centres for offering low-cost cancer diagnosis services.


Leave Your Comment
Thyrocare to launch B2C venture Lab Nation, scouting for strategic investors

Thyrocare to launch B2C venture Lab Nation, scouting for strategic investors

Jasleen Kaur Batra 4 years ago
Thyrocare Technologies Ltd, India’s largest thyroid testing company, is...
Norwest Venture Partners buying 10% stake in Thyrocare for $22M

Norwest Venture Partners buying 10% stake in Thyrocare for $22M

Madhav A Chanchani 5 years ago
Norwest Venture Partners said that it would invest Rs 120 crore or $22 million...
CX Partners part exits from Thyrocare, sells 2% stake to Emerging India Fund

CX Partners part exits from Thyrocare, sells 2% stake to Emerging India Fund

Madhav A Chanchani 4 years ago
CX Partners has made a partial exit from Mumbai-based Thyrocare Technologies Ltd...
No Comments

PE-backed Thyrocare founder on adopting a B2C model, exploring talks with strategic investor

Powered by WordPress.com VIP